跳至主要内容
临床试验/NCT04923711
NCT04923711Unknown不适用

A Perspective Randomized Controlled Study of the Formulation and Efficacy of Exercise Prescription for Patients With Coronary Heart Disease

Jing Ma1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Improvement of 6-minute walk test

研究概览

简要总结

The purposes of this study is to standardize the process of formulating exercise prescriptions for coronary heart disease(CHD), verify the safety and effectiveness of exercise prescriptions, and establish a database of exercise prescriptions for CHD, with a view to providing new solutions for cardiac rehabilitation.

详细描述

This study conducted a comparative study on the therapeutic effect and safety of exercise prescriptions for patients with coronary heart disease with different risk stratifications. The purposes of this study is to standardize the process of formulating exercise prescriptions for coronary heart disease(CHD), verify the safety and effectiveness of exercise prescriptions, and establish a database of exercise prescriptions for CHD, with a view to providing new solutions for cardiac rehabilitation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients aged 18-80 years old with a diagnosis of coronary heart disease,NYHA class I-III HF patients.

排除标准

  • •acute myocardial infarction within 2 weeks
  • •Uncontrolled tachycardia (heart rate at rest >120bpm
  • •Uncontrolled polypnea(breath rate at rest >30 breath per minute
  • •Uncontrolled respiratory failure (SPO2 ≤90%)
  • •Uncontrolled hyperglycemia (Random blood glucose>18mmol/L)
  • •Uncontrolled malignant arrhythmia with hemodynamic instability
  • •Uncontrolled septic shock and septicopyemia
  • •Uncooperation of the patients

研究组 & 干预措施

Moderate Intensity Group

Experimental

Group received a moderate exercise prescription of moderate intensity

干预措施: Moderate intensity exercise prescription (Behavioral)

High Intensity Group

Experimental

Group received a moderate exercise prescription of high intensity

干预措施: High intensity exercise prescription (Behavioral)

结局指标

主要结局

Improvement of 6-minute walk test

时间窗: 6 month

the improvement of 6 minute walking distance

Improvement of Cardiopulmonary exercise test

时间窗: 6 month

the improvement of maximum oxygen uptake

Improvement of grip strength test

时间窗: 6 month

the improvement of grip strength

Incidence of MACE

时间窗: 6 month

any incidence of the following: death, cardiac death, AMI, revascularization, stroke

Routine color Doppler echocardiography changed.

时间窗: 6 month

Routine color Doppler echocardiography changed.

The score of Seattle Angina Questionnaire increased

时间窗: 6 month

The score of Seattle Angina Questionnaire (SAQ, 0-100 each dimension, higher means greater condition)increased.

次要结局

  • The score of Patient Health Questionnaire decreased(6 month)
  • The score of Generalized Anxiexy Disorde-7 decreased(6 month)
  • The score of Pittsburgh Sleep Quality Index Scale decreased.(6 month)
  • The score of Fagerstrom Test for Nicotine Dependence decreased.(6 month)
  • The score of Medical Outcomes Study Questionnaire Short Form 36 Health Survey (36-Item Short Form Survey) increased(6 month)
  • The score of Chinese perceived stress scale decreased.(6 month)

研究者

发起方
Jing Ma
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jing Ma

Clincial professor

Chinese PLA General Hospital

研究点 (1)

Loading locations...

相似试验